205 related articles for article (PubMed ID: 15051798)
1. A rapid in vitro screening for delivery of peptide-derived peptidase inhibitors as potential drug candidates via epithelial peptide transporters.
Foltz M; Meyer A; Theis S; Demuth HU; Daniel H
J Pharmacol Exp Ther; 2004 Aug; 310(2):695-702. PubMed ID: 15051798
[TBL] [Abstract][Full Text] [Related]
2. Transport of angiotensin-converting enzyme inhibitors by H+/peptide transporters revisited.
Knütter I; Wollesky C; Kottra G; Hahn MG; Fischer W; Zebisch K; Neubert RH; Daniel H; Brandsch M
J Pharmacol Exp Ther; 2008 Nov; 327(2):432-41. PubMed ID: 18713951
[TBL] [Abstract][Full Text] [Related]
3. Importance of a small N-terminal region in mammalian peptide transporters for substrate affinity and function.
Döring F; Martini C; Walter J; Daniel H
J Membr Biol; 2002 Mar; 186(2):55-62. PubMed ID: 11944083
[TBL] [Abstract][Full Text] [Related]
4. Delta-aminolevulinic acid transport by intestinal and renal peptide transporters and its physiological and clinical implications.
Döring F; Walter J; Will J; Föcking M; Boll M; Amasheh S; Clauss W; Daniel H
J Clin Invest; 1998 Jun; 101(12):2761-7. PubMed ID: 9637710
[TBL] [Abstract][Full Text] [Related]
5. Identification of a potential substrate binding domain in the mammalian peptide transporters PEPT1 and PEPT2 using PEPT1-PEPT2 and PEPT2-PEPT1 chimeras.
Fei YJ; Liu JC; Fujita T; Liang R; Ganapathy V; Leibach FH
Biochem Biophys Res Commun; 1998 May; 246(1):39-44. PubMed ID: 9600064
[TBL] [Abstract][Full Text] [Related]
6. Peptide transport in the mammary gland: expression and distribution of PEPT2 mRNA and protein.
Groneberg DA; Döring F; Theis S; Nickolaus M; Fischer A; Daniel H
Am J Physiol Endocrinol Metab; 2002 May; 282(5):E1172-9. PubMed ID: 11934684
[TBL] [Abstract][Full Text] [Related]
7. Expression and functional characterization of the mammalian intestinal peptide transporter PepT1 in the methylotropic yeast Pichia pastoris.
Döring F; Theis S; Daniel H
Biochem Biophys Res Commun; 1997 Mar; 232(3):656-62. PubMed ID: 9126331
[TBL] [Abstract][Full Text] [Related]
8. Mechanism of intestinal absorption and renal reabsorption of an orally active ace inhibitor: uptake and transport of fosinopril in cell cultures.
Shu C; Shen H; Hopfer U; Smith DE
Drug Metab Dispos; 2001 Oct; 29(10):1307-15. PubMed ID: 11560874
[TBL] [Abstract][Full Text] [Related]
9. Valacyclovir: a substrate for the intestinal and renal peptide transporters PEPT1 and PEPT2.
Ganapathy ME; Huang W; Wang H; Ganapathy V; Leibach FH
Biochem Biophys Res Commun; 1998 May; 246(2):470-5. PubMed ID: 9610386
[TBL] [Abstract][Full Text] [Related]
10. An update on renal peptide transporters.
Daniel H; Rubio-Aliaga I
Am J Physiol Renal Physiol; 2003 May; 284(5):F885-92. PubMed ID: 12676733
[TBL] [Abstract][Full Text] [Related]
11. Transport of drugs by proton-coupled peptide transporters: pearls and pitfalls.
Brandsch M
Expert Opin Drug Metab Toxicol; 2009 Aug; 5(8):887-905. PubMed ID: 19519280
[TBL] [Abstract][Full Text] [Related]
12. Study of the mechanisms of uptake of 5-aminolevulinic acid derivatives by PEPT1 and PEPT2 transporters as a tool to improve photodynamic therapy of tumours.
Rodriguez L; Batlle A; Di Venosa G; MacRobert AJ; Battah S; Daniel H; Casas A
Int J Biochem Cell Biol; 2006; 38(9):1530-9. PubMed ID: 16632403
[TBL] [Abstract][Full Text] [Related]
13. PDZK1 regulates two intestinal solute carriers (Slc15a1 and Slc22a5) in mice.
Sugiura T; Kato Y; Wakayama T; Silver DL; Kubo Y; Iseki S; Tsuji A
Drug Metab Dispos; 2008 Jun; 36(6):1181-8. PubMed ID: 18322073
[TBL] [Abstract][Full Text] [Related]
14. PEPT1 involved in the uptake and transepithelial transport of cefditoren in vivo and in vitro.
Zhang Q; Liu Q; Wu J; Wang C; Peng J; Ma X; Liu K
Eur J Pharmacol; 2009 Jun; 612(1-3):9-14. PubMed ID: 19371738
[TBL] [Abstract][Full Text] [Related]
15. High-affinity interaction of sartans with H+/peptide transporters.
Knütter I; Kottra G; Fischer W; Daniel H; Brandsch M
Drug Metab Dispos; 2009 Jan; 37(1):143-9. PubMed ID: 18824524
[TBL] [Abstract][Full Text] [Related]
16. Noncompetitive inhibition of glycylsarcosine transport by quinapril in rabbit renal brush border membrane vesicles: effect on high-affinity peptide transporter.
Akarawut W; Lin CJ; Smith DE
J Pharmacol Exp Ther; 1998 Nov; 287(2):684-90. PubMed ID: 9808697
[TBL] [Abstract][Full Text] [Related]
17. The renal type H+/peptide symporter PEPT2: structure-affinity relationships.
Biegel A; Knütter I; Hartrodt B; Gebauer S; Theis S; Luckner P; Kottra G; Rastetter M; Zebisch K; Thondorf I; Daniel H; Neubert K; Brandsch M
Amino Acids; 2006 Sep; 31(2):137-56. PubMed ID: 16868651
[TBL] [Abstract][Full Text] [Related]
18. Molecular mechanisms of pulmonary peptidomimetic drug and peptide transport.
Groneberg DA; Fischer A; Chung KF; Daniel H
Am J Respir Cell Mol Biol; 2004 Mar; 30(3):251-60. PubMed ID: 14969997
[TBL] [Abstract][Full Text] [Related]
19. Pharmaceutical and pharmacological importance of peptide transporters.
Brandsch M; Knütter I; Bosse-Doenecke E
J Pharm Pharmacol; 2008 May; 60(5):543-85. PubMed ID: 18416933
[TBL] [Abstract][Full Text] [Related]
20. Transport characteristics of a novel peptide transporter 1 substrate, antihypotensive drug midodrine, and its amino acid derivatives.
Tsuda M; Terada T; Irie M; Katsura T; Niida A; Tomita K; Fujii N; Inui K
J Pharmacol Exp Ther; 2006 Jul; 318(1):455-60. PubMed ID: 16597710
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
